Glaxo Share Price
(GLAXO)
Check the latest share price of Glaxo, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹2902.2
▲1.84%
as on 04:01PM, 29 Apr 2025
NSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 2.14 % |
3 Month Return | + 34.69 % |
1 Year Return | + 44.63 % |
Market Stats | |
Previous Close | ₹2,849.80 |
Open | ₹2,849.00 |
Volume | 1.77L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹46,605.29Cr |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹46,605.29 Cr
Return on Equity (ROE)
80.48
Return on capital employed (ROCE)
32.13
P/B Ratio
10.52
Dividend Yield
5.41
EPS (TTM)
100.04
Sector
Pharmaceuticals
Investing in Glaxo is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Glaxo or GLAXO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Glaxo or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Glaxo with just a few clicks!
Track how the P/E of Glaxo has moved over time to understand valuation trends.
Glaxo in the last 5 years
Lowest (-81.64x)
December 28, 2020
Today (47.94x)
December 15, 2023
Industry (58.33x)
December 15, 2023
Highest (333.07x)
September 15, 2020
Today’s Price to Earnings Ratio: 47.94x
Get updated buy, sell, and hold recommendations by analysts on Glaxo.
based on 5 analysts
20.00%
Buy
60.00%
Hold
20.00%
Sell
60% of analysts recommend a 'HOLD' rating for Glaxo. Average target of ₹1434
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Glaxo.
Glaxo price forecast by 5 analysts
Downside of
High
₹1575
Target
₹1434.00
Low
₹1215
Glaxo target price ₹1434, a slight downside of -47.88% compared to current price of ₹2902.2. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Glaxo revenue growth forecast
Expected growth rate Q1, FY2025:12.81%
Forecast
Actual
Including amortisation and stock based compensations
Glaxo EPS growth forecast
EPS estimate Q1, FY2025:13.51%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Glaxo, including revenue, profit, loss and more.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Glaxo.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 75% | 0.00 | |
Foreign Institutions | 2.28% | 0.00 | |
Mutual Funds | 3.96% | 0.00 | |
Retail Investors | 12.43% | 0.00 | |
Others | 6.34% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Glaxo with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
HOLD | ₹46,605.29 Cr | 17.26% | 0.55 | NA | NA | |
BUY | ₹63,424.92 Cr | 22.06% | 0.55 | NA | NA | |
BUY | ₹87,426.64 Cr | 31.24% | 0.59 | NA | NA | |
BUY | ₹28,250.05 Cr | 30.32% | 0.64 | NA | NA | |
HOLD | ₹16,637.10 Cr | 6.43% | 0.57 | NA | NA |
Latest news and events at one place to help you take investing decisions in Glaxo.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 4.50% to 4.52% in Mar 2025 quarter
MF Holding Up
Mutual Funds have increased holdings from 4.96% to 5.17% in Mar 2025 quarter
Price Rise
In the last 3 months, GLAXO stock has moved up by 43.6%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 55.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.00% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 16.2%
Retail Holding Down
Retail Investor have decreased holdings from 13.19% to 12.69% in Mar 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.05K Cr → 984.49 Cr (in ₹), with an average decrease of 6.2% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 252.5 Cr → 229.88 Cr (in ₹), with an average decrease of 9.0% per quarter
Organisation | Glaxo |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Glaxo.
View the latest movement in Glaxo Futures & Options, including strike prices, expiry dates, and percentage changes.
Glaxosmithkline Pharmaceuticals Ltd share price today stands at ₹2902.2, Open: ₹2849, Previous Close: ₹2849.8, High: ₹2930.9, Low: ₹2810.1, 52 Week High: ₹3148, 52 Week Low: ₹1921.
Today's traded volume of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is 1.77L.
Today's market capitalisation of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is ₹46,605.29 Cr.
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) share price is ₹2902.2. It is down -7.81% from its 52 Week High price of ₹3148
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) share price is ₹2902.2. It is up 51.08% from its 52 Week Low price of ₹1921